Global Enteral Feeding Formula Market is expected to grow with the CAGR of 6.7% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.
Access full Report @ https://www.databridgemarketresearch.com/reports/global-enteral-feeding-formulas-market
Enteral feeding formula market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global enteral feeding formula market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio.
For instance
- In October 2017, Real Food Blends announced the launch of New Breakfast Meal Featuring Eggs, Apples & Oats. This meal is available for the people who cannot eat orally. The launch of the product provides high nutrition profile to the consumers.
Abbott is the dominating player in global enteral feeding formula market. The other key players existing in the market includes Nutricia Advanced Medical Nutrition, Hormel Foods Corporation, Victus, Inc., Global Health Products, Inc., Medline Industries, Inc, Mead Johnson & Company, LLC., Medtrition, Inc., Nutritional Medicinals, LLC, Real Food Blends, Nestlé Health Science, Meiji Holdings Co., Ltd., Fresenius Kabi Ltd (A subsidiary of Fresenius SE & Co. KGaA), and B. Braun Melsungen AG among others.
Abbott:
Abbott incorporated in 1894, headquarters in Illinois, U.S. The company is focused on bringing a change through access to healthcare, community engagement, science education and shared impact. The company is providing products under adult, pediatric, infants, ons, specialist, tolerance, tube feeds, freego, vitaflo. The market focus products lie under tube feeds category. The company is engaged in continuous development of enteral feeding formula.
- In August 2017, Abbott announced the partnership with the Changi General Hospital (CGH) (Singapore) which is supported by the Singapore Economic Development Board, to set up a Nutritional Health for the Elderly Reference Centre (NHERC) in Singapore. This partnership will help the company to drive and transform the healthcare professional in Singapore.
The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company has various subsidiaries such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.), Abbott Informatics (U.S.), CardioMEMS (U.S.), CFR Pharmaceuticals (Chile), Abbott GmbH & Co. KG (Germany) and others.
Nestlé Health Science
Nestlé Health Science headquartered in Vevey, Switzerlandwas founded in 2011. The company is focused on providing nutritional solutions designed to help improve patient outcomes, promote the dietary management of disease, and enhance patients’ quality of life. The company has multiple business segments such as powdered and liquid beverages, nutrition and health science, petcare, milk products and ice cream, prepared dishes and cooking aids, confectionery, water, in which nutrition and health science is the market focused segment. The company is providing products under tubing & formulas are the market focused product category. The company is engaged in continuous development of enteral feeding formula.
- In December 2017, Nestlé announced to acquire privately-held Atrium Innovations (Canada) to develop the new nutritional products. The product range of the Atrium Innovations will enhance the portfolio of the company by enabling consumers to address their health and wellness goals.
The company has wide presence across Americas, Asia-Pacific, and Europe. The company also has various subsidiary companies such as Atrium Innovations Inc. (Canada), Nutrition Science Partners Limited (Switzerland), Nutrition Science Partners Ltd (Switzerland), Brand Direct Health, L.L.C. (U.S.) among others.
Meiji Holdings CO., LTD
Meiji Holdings Co., Ltd. was incorporated in 2009 in Tokyo, Japan. The company is engaged in providing essential products such as dairy products, confectioneries, nutritionals and pharmaceuticals. The company is engaged in providing products in categories such as drinking milk, yogurt, functional yogurt, cheese, ice cream, chocolate, whey protein, infant formula, beauty supplement, enteral formula and nutritional products, ethical pharmaceuticals, agricultural chemicals and veterinary drugs among which enteral formula and nutritional products is the market focused category.
The company has wide presence across Asia-Pacific, Americas, Europe, Middle East Africa. The company has various subsidiary companies such as Meiji Co. Ltd (Japan), Nitto Co., Ltd. (Japan), Meiji Logitech (Japan), Meiji Dairies (Japan), Meiji Seika Food Industry (Shanghai) Co., Ltd. (China) and others. The company has initiated many strategic initiatives to expand its market.
For instance
- In March 2018, Meiji Holdings Co., Ltd., announced an agreement with Arysta LifeScience Corporation (U.S.) through which the company will be signing a license agreement for a new insecticide. With this agreement Meiji will receive an upfront payment as well as developmental milestone.
